Photo of Raj Mukherji
D New Jersey Senate · District 32

Sen. Raj Mukherji

Compare
Total votes
6,078
all sessions
Attendance
89%
467 missed
Near the chamber average
With party
99%
of cast votes
Higher than 75% of chamber peers
Bipartisan score
0%
crosses aisle rarely
Lower than 78% of chamber peers
Sponsored
1,901
bills & resolutions
Higher than 82% of chamber peers
Committees
3
assignments
6,078 roll-call votes

Voting record

Yea
5,853
voted in favor
Nay
10
voted against
Absent
467
missed votes
Total cast
6,078
across all sessions
Crossed party
10
votes against own party
This page
6,078
matching current filters
Bill
Description
Vote
Result
Tally
Date
A 1639
Increases personal needs allowance to $50 for recipients of Medicaid and Supplemental Security Income who are veterans or spouses of veterans and provides for annual cost-of-living increase in allowance.
Other
Passed
69–0
Oct 20, 2016
A 747
Requires State Treasurer to organize and publish certain contract and grant data and information on State expenditure Internet website.
Other
Passed
68–0
Oct 20, 2016
A 1185
Requires State Comptroller to report findings of audit compliance reviews.
Other
Passed
69–0
Oct 20, 2016
AJR 87
Recognizes 100th anniversary of Farm Credit East Program.
Other
Passed
69–0
Oct 20, 2016
A 224
Provides for licensing of pool and spa service contractors, and pool and spa builders and installers.
Other
Passed
51–12
Oct 20, 2016
AR 185
Authorizes Assembly Judiciary Committee to enter upon investigation or inquiry into financial and operating practices of NJ Transit; grants committee subpoena power.
Other
Passed
49–21
Oct 20, 2016
AR 149
Urges United States Air Force to base F-35 fighter jets at 177th Fighter Wing in Atlantic City.
Other
Passed
65–0
Oct 20, 2016
A 2451
"Aid in Dying for the Terminally Ill Act"; permits qualified terminally ill patient to self-administer medication to end life in humane and dignified manner.
Other
Passed
39–28
Oct 20, 2016
A 316
Requires an annual State debt affordability analysis be included in the State Debt Report.
Other
Passed
64–5
Oct 20, 2016
S 2024
Clarifies that product approval from U.S. Food and Drug Administration is not required for drug manufacturer to file registration statement, and specifies timeframe by which DOH must review registration statements.
Other
Passed
69–0
Oct 20, 2016
Showing 5,651 to 5,660 of 6,078 votes